Company / Capital Returned to Shareholders per Share
Catalyst Pharmaceuticals Partners, Inc. Capital Returned to Shareholders per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.21
FY2025
5-year range
$0.00 / $0.21
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#38 of 51
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s capital returned to shareholders per share of $0.21 is lower than 75% of companies in the Health Care sector (FY2025). Improved from $0.00 to $0.21 over the past 2 years.
Based on SEC 10-K filings.
0.21 in FY2025 with a 3-year CAGR of +46.5%.
Improved from $0.00 to $0.21 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +46.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-92.4% below sector average
Key checks
Key Insights
- Ranks #38 out of 51 companies in the Health Care sector.
- Lowest capital returned to shareholders per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.21 | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.07 | -44.1% |
| FY2021 | $0.12 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026